JPS63283552A - Health food mainly containing kind of sweet potato originating from brazil - Google Patents
Health food mainly containing kind of sweet potato originating from brazilInfo
- Publication number
- JPS63283552A JPS63283552A JP62118270A JP11827087A JPS63283552A JP S63283552 A JPS63283552 A JP S63283552A JP 62118270 A JP62118270 A JP 62118270A JP 11827087 A JP11827087 A JP 11827087A JP S63283552 A JPS63283552 A JP S63283552A
- Authority
- JP
- Japan
- Prior art keywords
- sweet potato
- health food
- extract
- brazil
- originating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 17
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 17
- 235000013402 health food Nutrition 0.000 title claims abstract description 12
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 13
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 13
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims abstract description 13
- 229950005143 sitosterol Drugs 0.000 claims abstract description 13
- 229940076810 beta sitosterol Drugs 0.000 claims abstract description 12
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 9
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 9
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 9
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 9
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims abstract description 8
- 150000003648 triterpenes Chemical class 0.000 claims abstract description 6
- 150000002148 esters Chemical class 0.000 claims abstract description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims description 4
- 230000007774 longterm Effects 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 abstract 2
- 229960002666 1-octacosanol Drugs 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 6
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- ZUQOBHTUMCEQBG-UHFFFAOYSA-N 4-amino-5-hydroxynaphthalene-1,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(N)=CC=C(S(O)(=O)=O)C2=C1 ZUQOBHTUMCEQBG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 235000019780 Liver Tonic Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- -1 ferulic acid ester Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000876 liver tonic Substances 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、ブラジル原産の白甘藷（ＩＰＯＭＥＡ Ｂ
ａｔａｔａｓ、Ｒ，ｖａｒ、ＳＩＭＯＮ）の抽出物であ
るβ−シトステロール、フェルラ酸およびそのエステル
、トリテルペノイド、オコタコサノール等を含有せる健
康食品に関するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention is directed to white sweet potato (IPOMEA B) native to Brazil.
The present invention relates to a health food containing β-sitosterol, ferulic acid and its esters, triterpenoids, ocotacosanol, etc., which are extracts of P. atas, R. var., SIMON).
（従来の技術〕
白甘藷（レモン１号）は、ブラジル連邦国立農科大学Ｅ
ＳＡＬのシモン教授によって発見され。(Conventional technology) White sweet potato (Lemon No. 1) is produced by E.
Discovered by Professor Simon of SAL.
その後、楊天和博士によって日本に持ち込まれ、四国で
栽培実験と医療研究を重ねた結果、この白甘藷には天然
ビタミンＢいＢ８、ＢいＣ，Ｅ、Ｐ、Ｋ、ニコチン酸、
パントテン酸、葉酸、葉緑素、カリウム、カルシウム等
ミネラルが普通栽培されている日本国内市場の甘藷より
もこれらの成分が豊富に含有されていることが判明し、
更に栽培と分析の研究を重ねた結果、ビタミン、ミネラ
ルは勿論ビタミンにと葉酸の一種であるヤラピン酸が含
まれていることが判明し、更には葉緑素の前階物質（ポ
ルフィリン）が含まれていることが判明した。Afterwards, it was brought to Japan by Dr. Yang Tianhe, and as a result of repeated cultivation experiments and medical research in Shikoku, this white sweet potato contains natural vitamins B, B8, B, C, E, P, K, and nicotinic acid.
It was found that the minerals such as pantothenic acid, folic acid, chlorophyll, potassium, and calcium are richer in these ingredients than sweet potato grown in the Japanese domestic market, which is commonly cultivated.
As a result of further cultivation and analysis research, it was discovered that it contains not only vitamins and minerals, but also yalapic acid, a type of folic acid, as well as a precursor to chlorophyll (porphyrin). It turned out that there was.
このように、ブラジル原産白甘藷には各種の薬効成分が
豊富に含まれていて、これらの成分が相乗的に効果をも
たらすことで糖尿病、高血圧、低血圧、神経痛等のいろ
いろな難病に有効であることは既に知られているが、そ
れ以上の成分の含有分析については研究がなされていな
かった。In this way, Brazilian white sweet potato is rich in various medicinal ingredients, and these ingredients have a synergistic effect, making it effective for various intractable diseases such as diabetes, high blood pressure, low blood pressure, and neuralgia. Although it is already known that there is such a thing, no research has been conducted on the content analysis of any further components.
そこで、本発明者等は、この薬効成分を豊富に含有せる
ブラジル原産白甘藷には更に未知なる因子が含有されて
いるとの前提に鋭意研究を重ねた結果、β−シトステロ
ール等の成分が多量に含有されていることを見い出し、
かつこの白せ藷の健康食品としての高度利用力ためには
、白せ藷のβ−シトステロール等の成分を抽出し、不要
な部分を除去したものを利用するのが極めて効果的であ
ることを見い出し、本発明を完成したものである。Therefore, the present inventors conducted intensive research on the premise that Brazilian white sweet potato, which is rich in medicinal ingredients, also contains unknown factors, and found that it contains large amounts of components such as β-sitosterol. found that it is contained in
In order to utilize this white horsetail as a health food, it is extremely effective to extract components such as β-sitosterol from white horsetail and remove unnecessary parts. The heading completes the invention.
本発明に係る健康食品はブラジル原産白甘藷抽出物を含
有するものであるが、これら抽出物はクロロホルムおよ
びメタノール抽出により得られる。The health food according to the present invention contains Brazilian white sweet potato extracts, and these extracts are obtained by chloroform and methanol extraction.
ブラジル原産の白せ藷は日本国内市場品の甘藷とは大き
く異なり、表皮の色は白く、根茎には大きな孔管があっ
てこの乳液は空気にふれると酸化され速やかに異変する
。White potato, which is native to Brazil, is very different from the sweet potato sold in Japan.The color of the skin is white, and the rhizome has large pore tubes.When exposed to air, this milky sap oxidizes and changes quickly.
そこで、白せ藷の皮をむき、乾燥後、クロロホルムを用
いて抽出した。そのエキスについて薄層クロマトグラフ
ィー（吸着剤：メルク社製シリカゲルＧＦ２５４、展開
溶媒；クロロホルム、検出法； Ｖ Ｖ ２５４ ｎ
ｍで消光するスポットを確認並びに１０％硫酸噴−後着
色するまで加熱）を行うと、含有物としてβ−シトステ
ロール、フェルラ酸、フェルラ酸エステル、高級脂肪酸
アルコール、オコタコサノールが得られた。Therefore, the white potatoes were peeled, dried, and extracted using chloroform. The extract was subjected to thin layer chromatography (adsorbent: silica gel GF254 manufactured by Merck & Co., Ltd., developing solvent: chloroform, detection method: V V 254 n
After confirming the spot where the light was quenched with m and spraying with 10% sulfuric acid and heating until colored, β-sitosterol, ferulic acid, ferulic acid ester, higher fatty acid alcohol, and ocotacosanol were obtained as contained substances.
また、同様にクロロホルム抽出エキスについて薄層クロ
マトグラフィーを前記した条件（但し、展開溶媒はクロ
ロホルム：メタノール＝１０：１）で行うとトリテルペ
ノイドが得られた。Similarly, triterpenoids were obtained by performing thin layer chromatography on the chloroform extract under the conditions described above (however, the developing solvent was chloroform:methanol=10:1).
含有物中のβ−シトステロールは他の植物からも分離さ
れているが、本日甘藷中の含量はかなり多く、このβ−
シトステロールは女性ホルモン（ロホウホルモン）作用
を有し、女性のみならず、男性の健康に対しても有用で
ある。Although β-sitosterol in the content has been isolated from other plants, the content in sweet potatoes today is quite high;
Sitosterol has a female hormone (rohou hormone) effect and is useful not only for the health of women but also for men.
また、フェルラ酸の高給脂肪酸アルコールおよびトリテ
ルペノイドは利胆作用を有し、また、オコタコサノール
は渡り鳥の活性源であり筋力の持続をもたらすもので、
これら化合物は通常含有されている植物に比して本山甘
藷には多量に含まれている。In addition, the high fatty acid alcohol and triterpenoids of ferulic acid have a choleretic effect, and ocotacosanol is an active source for migratory birds and maintains muscle strength.
These compounds are contained in larger amounts in Motoyama sweet potato than in plants that normally contain them.
また、白せ藷をその端から輪切りにしながら、その孔管
から分泌する乳液をアスピレータ−を用いて採集し、凍
結乾燥したメタノール可溶分について薄層クロマトグラ
フィーを前記した条件（但し、展開溶媒はクロロホルム
のみ）で行うと含有物としてβ−シトステロールが得ら
れた。In addition, while cutting the white potato into rounds from the end, the milky liquid secreted from the pore tubes was collected using an aspirator, and the lyophilized methanol-soluble content was subjected to thin layer chromatography under the conditions described above (however, the developing solvent When the reaction was carried out using only chloroform), β-sitosterol was obtained as the content.
次に、白せ藷の皮をメタノールで抽出し、得られエキス
を水に溶解し、酢酸エチル層について薄層クロマトグラ
フィーを行ったところβ−シトステロールが得られた。Next, the skin of white potato was extracted with methanol, the obtained extract was dissolved in water, and the ethyl acetate layer was subjected to thin layer chromatography, and β-sitosterol was obtained.
更に残りの水層に水飽和ブタノールを加え、分配し、ブ
タノール層を得、これについて薄層クロマトグラフィー
を行ったところβ−シトステロールが得られた。Furthermore, water-saturated butanol was added to the remaining aqueous layer and the mixture was partitioned to obtain a butanol layer. When thin layer chromatography was performed on this layer, β-sitosterol was obtained.
そして、これら健康保持に役立つ含有物は分解せずに固
形化または長期保存に耐え得るようにするため、凍結乾
燥、減圧乾燥、冷風ジェット粉砕等の処理がなされ、か
つ好ましくは、根茎の部分と葉茎の部分との比が３＝７
から７：３の割合で混合された粉末または固形物とされ
る。In order to solidify or endure long-term storage without decomposition, these health-promoting substances are processed by freeze-drying, vacuum drying, cold-air jet pulverization, etc., and are preferably combined with rhizomes. The ratio of the leaf stem part is 3=7
It is made into a powder or solid substance mixed at a ratio of 7:3.
しかして、本発明によれば、その健康食品の主体をなす
ブラジル原産の白せ藷には、女性ホルモン作用を有する
ばかりか、男性の健康に対しても有用であるβ−シトス
テロールや胆汁分泌促進並びに強肝剤としての成分であ
るフェルラ酸、更には渡り鳥の活性源であり筋力の持続
をもたらすオコタコサノール等の成分が通常含有されて
いる植物に比して多量に含有されており、これらの薬効
成分の相乗的効果によって極め効果の高い健康食品を提
供し得るものである。According to the present invention, the white potato, which is native to Brazil and which is the main ingredient of the health food, not only has a female hormone effect, but also contains β-sitosterol, which is useful for men's health, and bile secretion promoting. In addition, it contains larger amounts of ingredients such as ferulic acid, which is a liver tonic, and ocotacosanol, which is an active source of migratory birds and maintains muscle strength, than plants that normally contain, and these medicinal effects are enhanced. The synergistic effects of the ingredients make it possible to provide highly effective health foods.
Claims (1)
酸およびそのエステル、オコタコサノール、フェルラ酸
の高級脂肪アルコールおよびトリテルペノイドである特
許請求の範囲第１項記載の健康食品。 ３、前記白甘藷抽出物が、固形化され、または長期保存
に耐え得るように処理された特許請求の範囲第１項記載
の健康食品。 ４、前記白甘藷抽出物が、根茎部分の抽出物と葉茎部分
の抽出物との比が３：７から７：３の割合で混合された
粉末または固形物である特許請求の範囲第１項記載の健
康食品。[Claims] 1. Health food containing Brazilian white sweet potato extract. 2. The health food according to claim 1, wherein the white sweet potato extract is β-sitosterol, ferulic acid and its esters, ocotacosanol, higher fatty alcohols of ferulic acid, and triterpenoids. 3. The health food according to claim 1, wherein the white sweet potato extract is solidified or treated to withstand long-term storage. 4. Claim 1, wherein the white sweet potato extract is a powder or solid substance in which the ratio of the extract of the rhizome part to the extract of the leaf and stem part is mixed in a ratio of 3:7 to 7:3. Health foods listed in section.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62118270A JPS63283552A (en) | 1987-05-15 | 1987-05-15 | Health food mainly containing kind of sweet potato originating from brazil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62118270A JPS63283552A (en) | 1987-05-15 | 1987-05-15 | Health food mainly containing kind of sweet potato originating from brazil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS63283552A true JPS63283552A (en) | 1988-11-21 |
Family
ID=14732483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62118270A Pending JPS63283552A (en) | 1987-05-15 | 1987-05-15 | Health food mainly containing kind of sweet potato originating from brazil |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63283552A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU660935B2 (en) * | 1991-09-04 | 1995-07-13 | Keigo Kusano | Preservative auxiliary material for food |
| DE10215055A1 (en) * | 2002-04-03 | 2003-10-30 | Univ Schiller Jena | Antiinflammatory or pre-neoplastic lesion inhibiting medicaments containing caffeic acid triterpene or sterol esters having radical scavenging action, also useful in cosmetic or nutraceutical compositions |
| JP2004075638A (en) * | 2002-08-21 | 2004-03-11 | Okinawa Pref Gov | Functional material having action to suppress increase of blood sugar level and suppress increase of blood pressure |
| JP2004277411A (en) * | 2003-02-19 | 2004-10-07 | Toyo Shinyaku:Kk | Dried powder of sweet potato starch lees and composition containing the same |
| WO2004105739A1 (en) * | 2003-05-28 | 2004-12-09 | Eisai Co., Ltd. | Compositions and foods and drinks contiaing higher fatty acid derivative |
| WO2005105852A1 (en) * | 2004-04-30 | 2005-11-10 | Fuji-Sangyo Co., Ltd. | Novel arabinogalactan, substance with antidiabetic activity and method of use thereof |
| WO2005112665A1 (en) * | 2004-05-21 | 2005-12-01 | Toyo Shinyaku Co., Ltd. | Composition containing processed sweet potato foliage |
| WO2005115423A1 (en) * | 2004-05-31 | 2005-12-08 | Munisekhar Medasani | Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same |
| WO2006014864A3 (en) * | 2004-07-26 | 2006-03-30 | Wyeth Corp | Methods and compositions for reducing c-reactive protein |
| JP2006182738A (en) * | 2004-12-28 | 2006-07-13 | Ipe:Kk | Rice grain for diabetes and cooked rice using the same |
| KR100625469B1 (en) | 2005-06-15 | 2006-09-20 | 경상대학교산학협력단 | Method of extracting frulic acid from sweet potato stem |
| WO2007013522A1 (en) * | 2005-07-27 | 2007-02-01 | Dna Bank Co., Ltd. | Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
-
1987
- 1987-05-15 JP JP62118270A patent/JPS63283552A/en active Pending
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU660935B2 (en) * | 1991-09-04 | 1995-07-13 | Keigo Kusano | Preservative auxiliary material for food |
| DE10215055A1 (en) * | 2002-04-03 | 2003-10-30 | Univ Schiller Jena | Antiinflammatory or pre-neoplastic lesion inhibiting medicaments containing caffeic acid triterpene or sterol esters having radical scavenging action, also useful in cosmetic or nutraceutical compositions |
| JP2004075638A (en) * | 2002-08-21 | 2004-03-11 | Okinawa Pref Gov | Functional material having action to suppress increase of blood sugar level and suppress increase of blood pressure |
| JP2004277411A (en) * | 2003-02-19 | 2004-10-07 | Toyo Shinyaku:Kk | Dried powder of sweet potato starch lees and composition containing the same |
| WO2004105739A1 (en) * | 2003-05-28 | 2004-12-09 | Eisai Co., Ltd. | Compositions and foods and drinks contiaing higher fatty acid derivative |
| JPWO2005105852A1 (en) * | 2004-04-30 | 2008-03-13 | 富士産業株式会社 | Novel arabinogalactan and antidiabetic agent and method of use thereof |
| WO2005105852A1 (en) * | 2004-04-30 | 2005-11-10 | Fuji-Sangyo Co., Ltd. | Novel arabinogalactan, substance with antidiabetic activity and method of use thereof |
| WO2005112665A1 (en) * | 2004-05-21 | 2005-12-01 | Toyo Shinyaku Co., Ltd. | Composition containing processed sweet potato foliage |
| JPWO2005112665A1 (en) * | 2004-05-21 | 2008-03-27 | 株式会社東洋新薬 | Composition containing processed sweet potato stems and leaves |
| WO2005115423A1 (en) * | 2004-05-31 | 2005-12-08 | Munisekhar Medasani | Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same |
| WO2006014864A3 (en) * | 2004-07-26 | 2006-03-30 | Wyeth Corp | Methods and compositions for reducing c-reactive protein |
| JP2006182738A (en) * | 2004-12-28 | 2006-07-13 | Ipe:Kk | Rice grain for diabetes and cooked rice using the same |
| KR100625469B1 (en) | 2005-06-15 | 2006-09-20 | 경상대학교산학협력단 | Method of extracting frulic acid from sweet potato stem |
| WO2007013522A1 (en) * | 2005-07-27 | 2007-02-01 | Dna Bank Co., Ltd. | Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
| JP2007031338A (en) * | 2005-07-27 | 2007-02-08 | Dna Bank:Kk | Extract of ipomoea batatas sp., sphingoglycolipid derived from ipomoea batatas sp. and method for producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0282002A2 (en) | Compositions of oats and nettle extracts to be used as a food additive or pharmaceutical preparation in human health care | |
| JP2005008572A (en) | Lipase inhibitor | |
| DE19627344A1 (en) | Therapeutic composition containing epicatechin and/or theaflavin | |
| JPS63283552A (en) | Health food mainly containing kind of sweet potato originating from brazil | |
| DE4242149A1 (en) | ||
| CN101203277B (en) | Hair tonic | |
| JP3170070B2 (en) | External preparation for skin | |
| JP2022533930A (en) | Spray composition for improving scalp health containing Houttuynia cordata component | |
| CN104095783A (en) | Traditional Chinese medicine antiphlogistic and acne-removing beauty cream and preparation method thereof | |
| WO2002066041A1 (en) | Natural composition | |
| CN110477397B (en) | Method for preparing dendrobium flower extracting solution and application thereof | |
| DE10308298A1 (en) | Production of a plant preparation useful for treating cancer comprises extracting glucosinolates from plant material and enzymatically hydrolyzing the glucosinolates to isothiocyanates | |
| US7112344B2 (en) | Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof | |
| CN105597081A (en) | Medicine for reducing hypertension | |
| KR20030091616A (en) | Manufacture of a substance for improving bone density | |
| JPH09208479A (en) | Salicaceae plant mixture | |
| Dharmananda | Sea buckthorn | |
| JP2001192342A (en) | Method for producing mixture of liquid formulation of concentrated stevia with ripe punica granatum | |
| JP4197194B2 (en) | Oral administration agent for intercellular adhesion suppression | |
| JP3432596B2 (en) | Hair restorer | |
| CN110643425A (en) | Chinese herbal medicine type animal fat deodorization agent and preparation method and application thereof | |
| Kivirantat et al. | Effects of onion and garlic extracts on spontaneously hypertensive rats | |
| KR100946690B1 (en) | Cosmetic composition with anti inflammation effect containing fermented extract of organic tomato, Prunus mume Sieb.Et Zucc, unshui citrus, peach and aloe | |
| US7282226B2 (en) | Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof | |
| CN108653423A (en) | A kind of Chinese medicine composition and its preparation prevented or treat chronic cheilitis |